Topic Archives: JPMorgan Chase (JPM)

This article originally ran on January 12… the teaser pitch was still being circulated heavily last week, and the stock released earnings on February 3 that disappointed investors, bringing shares down about 15% (it was teased as a “$7 biotech,” and briefly $8, before then). The original Jan. 14 “special event” catalyst teased by Lichtenfeld, […]

These are my notes and instant reactions from a presentation at the Value Investing Congress, the notes below might contain errors, paraphrases, incorrect quotes, or misinterpretations. Richard Lashley at PL Capital has been involved in proxy contests and shareholder activism with small banks around the country for about 18 years. Chris Mayer talked about him […]

Ed. note: Today we have another piece from Myron Martin, who writes for us primarily about junior miners. He has agreed to our trading restrictions, and, as usual, we have not reviewed, approved or screened his stocks or ideas, and the opinions he expresses are solely his own.  Myron’s past commentaries can be seen here. There […]

This is one of those teaser ads that’s really tough to resist — a “hidden” investment that “you were never meant to know about,” a secret bargain, leveraged returns, they’re genuinely “contrarian,” and … and this is no small feat … the ad makes you feel like you can actually get the benefit of those […]

Comments

  • Avatar

    The discussion of Epidiolex caused me to wonder what Docc Gumshoe's thoughts are on OTC hemp oil CBDs. I have friends w...

  • Avatar

    Thanks MJ, This is the real reason I read stockgumshoe.Having worked in the “Health care” profession for decad...

  • We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.

    More Info